The Pentagon is pausing guidelines under a controversial policy to require testosterone testing for service members over the age of 30, Reuters reports.
The policy, which was announced in July, mandated that military personnel would get testosterone screening from age 30 and older as part of their annual physical. The goal of the program was to optimize performance and to keep officers “on the leading edge of lethality,” according to Secretary of War Pete Hegseth.
Draft clinical guidance for that testing was posted online on Wednesday, but was later removed, according to Reuters. In a statement to Scientific American, a Pentagon official confirmed the removal and said it was a temporary move pending further updates.
On supporting science journalism
If you’re enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.
“The ‘Interim Guidance on Testosterone Deficiency Screenings for Active Duty and Reserve Component Personnel’ remains in effect” in the meantime, the spokesperson said. “The final clinical guidance will be issued shortly.”
Testosterone is a sex hormone involved in hair and muscle growth and sex drive, among other functions, in cisgender men. In women, testosterone also supports libido, muscle growth, menstrual health and more.
As Scientific American previously reported, there’s evidence that testosterone replacement therapy (TRT) can help improve libido and mood in adult men with very low testosterone—often defined as lower than 300 nanograms per deciliter (ng/dl)—but it can come with side effects such as reduced fertility. There’s also some evidence it can help treat low libido in postmenopausal women.
TRT is currently only approved by the U.S. Food and Drug Administration for men with low testosterone and a medical condition such as testicular cancer or pituitary disease, which can affect T levels.
But the symptoms of low testosterone—such as low energy and low libido—are common as people age and may have all sorts of causes, according to the Endocrine Society. As such, the organization says, there is “insufficient evidence” for wide screening in men without symptoms.
Subscribe to Support Independent Journalism
Great science journalism requires human expertise, time, effort and creativity. And it costs money. That’s why I and the journalists here at Scientific American hope you’ll join our community.
When you subscribe, you are supporting staff and freelance journalists who are passionate about telling science stories that are true, important and compelling. Our editors and reporters are often experts in their fields, which means they understand the nuances of big discoveries and can untangle the breakthroughs from the hype. With a subscription, you are also supporting rigorous fact-checking to ensure the words we publish are precise and accurate. And you’re supporting original illustrations, graphics and photos that bring you closer to an advanced laboratory, an ice sheet in Antarctica or a space mission in orbit. You’re helping us craft other types of high-quality journalism as well: Our newsletters are carefully written, edited and curated by staffers you have or will come to know and love. Our Science Quickly podcast is based on original reporting, collaboration with editors and scientists and exacting production.
Subscriptions keep this engine running so we can continue to deliver thoughtful, rigorous and independent science journalism to you. In an era of viral misinformation, this work is crucial. If you value what we do, I hope you’ll consider joining us as a subscriber
